PROVECTUS BIOPHARMACEUTICALS INC Common Stock
Why Robinhood?
You can watch PVCT and buy or sell other stocks, ETFs, and their options commission-free!About PVCT
Provectus Biopharmaceuticals, Inc. is a development stage biopharmaceutical company, which engages in the development of ethical pharmaceuticals for oncology and dermatology indications. Its prescription drugs treat several life-threatening cancers including metastatic melanoma, liver cancer, and breast cancer.
PVCT Key Statistics
Stock Snapshot
The current PROVECTUS BIOPHARMACEUTICALS INC Common Stock(PVCT) stock price is $0.07, with a market capitalization of 29.4M. The stock trades at a price-to-earnings (P/E) ratio of -4.30.
On 2025-12-07, PROVECTUS BIOPHARMACEUTICALS INC Common Stock(PVCT) stock traded between a low of $0.06 and a high of $0.07. Shares are currently priced at $0.07, which is +9.5% above the low and -5.6% below the high.
The PROVECTUS BIOPHARMACEUTICALS INC Common Stock(PVCT)'s current trading volume is 52.98K, compared to an average daily volume of 348.82K.
During the past year, PROVECTUS BIOPHARMACEUTICALS INC Common Stock(PVCT) stock moved between $0.05 at its lowest and $0.15 at its peak.
During the past year, PROVECTUS BIOPHARMACEUTICALS INC Common Stock(PVCT) stock moved between $0.05 at its lowest and $0.15 at its peak.